NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 17 filers reported holding NEMAURA MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,829 | -65.3% | 107,897 | 0.0% | 0.00% | – |
| Q2 2023 | $100,322 | +6.3% | 107,897 | 0.0% | 0.00% | – |
| Q1 2023 | $94,409 | +51489.6% | 107,897 | 0.0% | 0.00% | – |
| Q4 2022 | $183 | -99.9% | 107,897 | -0.3% | 0.00% | – |
| Q3 2022 | $225,000 | -19.4% | 108,182 | 0.0% | 0.00% | – |
| Q2 2022 | $279,000 | -40.9% | 108,182 | 0.0% | 0.00% | – |
| Q1 2022 | $472,000 | -4.3% | 108,182 | -0.0% | 0.00% | – |
| Q4 2021 | $493,000 | -24.2% | 108,203 | -0.0% | 0.00% | – |
| Q3 2021 | $650,000 | -25.7% | 108,215 | +27.9% | 0.00% | – |
| Q2 2021 | $875,000 | -14.8% | 84,622 | -37.1% | 0.00% | – |
| Q1 2021 | $1,027,000 | +326.1% | 134,488 | +110.2% | 0.00% | – |
| Q4 2020 | $241,000 | +14.2% | 63,981 | +7.4% | 0.00% | – |
| Q3 2020 | $211,000 | -46.9% | 59,573 | +38.7% | 0.00% | – |
| Q2 2020 | $397,000 | – | 42,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
| VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
| UBS Group AG | 85 | $27 | 0.00% |
| NewEdge Advisors, LLC | 360 | $113 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |